Skip to main content
Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

149 wyświetleń
Pobierz
Farmaceutyczny

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Zaawansowana formuła farmaceutyczna do celowanego działania terapeutycznego.

Dawkowanie

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Moc

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Wielkość opakowania

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Postać

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Źródło

European Medicines Agency

Zobacz źródło

Profil bezpieczeństwa

Przeciwwskazania

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Skutki uboczne

Ranexa-H-C-PSUSA-00002611-201501: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Powiązane artykuły kliniczne